elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38608260-18927817-7BC2-4A74-8AA4-C6D63AB57002
Q38608260-18927817-7BC2-4A74-8AA4-C6D63AB57002
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38608260-18927817-7BC2-4A74-8AA4-C6D63AB57002
Targeting key proximal drivers of type 2 inflammation in disease.
P2860
Q38608260-18927817-7BC2-4A74-8AA4-C6D63AB57002
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38608260-18927817-7BC2-4A74-8AA4-C6D63AB57002
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5188a1430bf5bf136cfe0cba031561478e2b7858
P2860
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.